{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:10:52Z","timestamp":1793988652705,"version":"4.8.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory demyelinating disease that is distinct from multiple sclerosis. Initial manifestations of MOGAD that were reported in the literature included optic neuritis, myelitis, brainstem demyelination and encephalitis, with emphasis placed on acute disseminated encephalomyelitis (ADEM) as the primary encephalitic presentation. In 2017, however, Ogawa et al. described four patients with seizures, unilateral cortical hyperintensities on brain magnetic resonance imaging T2-fluid-attenuated inversion recovery sequences, and anti-MOG positivity, indicating a potentially novel form of encephalitis in MOGAD. In 2019, we systematically reviewed the literature to better characterize this unique syndrome, which we referred to as unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES). Subsequently, anti-MOG positivity in patients with a variety of cortical and meningeal disease presentations has been reported, indicating a broader spectrum of meningo-cortical manifestations in MOGAD that we review herein.<\/jats:p>","DOI":"10.3389\/fneur.2022.1044642","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T01:15:34Z","timestamp":1666228534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum"],"prefix":"10.3389","volume":"13","author":[{"given":"Adrian","family":"Budhram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ario","family":"Mirian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm1488","article-title":"Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein","volume":"13","author":"O'Connor","year":"2007","journal-title":"Nat Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"885218","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and mri features, diagnosis, and management","volume":"13","author":"Sechi","year":"2022","journal-title":"Front Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","article-title":"Unilateral cortical FLAIR-hyperintense lesions in anti-MOG-associated Encephalitis with seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome","volume":"266","author":"Budhram","year":"2019","journal-title":"J Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"102729","DOI":"10.1016\/j.msard.2020.102729","article-title":"FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) unmasked by withdrawal of immunosuppression for Crohn's disease?","volume":"48","author":"Stamenova","year":"2021","journal-title":"Mult Scler Relat Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"102759","DOI":"10.1016\/j.msard.2021.102759","article-title":"FLAMES: a novel burning entity in MOG IgG associated disease","volume":"49","author":"Jain","year":"2021","journal-title":"Mult Scler Relat Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.nrl.2021.06.002","article-title":"FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) in a patient with Crohn's disease on anti-TNF treatment","volume":"30","author":"Cabezudo-Garc\u00eda","year":"2021","journal-title":"Neurologia."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9439","DOI":"10.2169\/internalmedicine.9439-22.","article-title":"A case report of FLAMES with elevated myelin basic protein followed by myelitis","author":"Hokama","year":"2022","journal-title":"Intern Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s10072-020-04892-7","article-title":"Anti-MOG-associated demyelinating disorders: two sides of the same coin","volume":"42","author":"Maniscalco","year":"2021","journal-title":"Neurol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/CON.0000000000000900","article-title":"Myelitis and other autoimmune myelopathies","volume":"27","author":"Lopez Chiriboga","year":"2021","journal-title":"Continuum."},{"key":"B19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"103727","DOI":"10.1016\/j.msard.2022.103727","article-title":"Clinical analysis of adult MOG antibody-associated cortical encephalitis","volume":"60","author":"Yao","year":"2022","journal-title":"Mult Scler Relat Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"782490","DOI":"10.3389\/fnhum.2021.782490","article-title":"Myelin oligodendrocyte glycoprotein antibody associated cerebral cortical encephalitis: case reports and review of literature","volume":"15","author":"Shu","year":"2021","journal-title":"Front Hum Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.nerep.2022.100096","article-title":"Decreased subcortical T2 FLAIR signal with cortical T2 FLAIR hyperintense lesions in unilateral cerebral cortical encephalitis with myelin oligodendrocyte glycoprotein antibody","volume":"2","author":"Fujimori","year":"2022","journal-title":"Neuroimmunol Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"600169","DOI":"10.3389\/fneur.2020.600169","article-title":"Clinical and radiological features of adult onset bilateral medial frontal cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody","volume":"11","author":"Fujimori","year":"2020","journal-title":"Front Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"104126","DOI":"10.1016\/j.msard.2022.104126","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: a novel phenotype","volume":"68","author":"Lin","year":"2022","journal-title":"Multiple Sclerosis Related Disorders."},{"key":"B25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pediatrneurol.2020.05.003","article-title":"Unilateral cortical fluid-attenuated inversion recovery-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein-associated encephalitis with seizures (FLAMES): an under-recognized entity","volume":"110","author":"Budhram","year":"2020","journal-title":"Pediatr Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14581\/jer.15004","article-title":"Anti-NMDA receptor antibody encephalitis presenting with unilateral non-convulsive status epilepticus in a male patient","volume":"5","author":"Kim","year":"2015","journal-title":"J Epilepsy Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2169\/internalmedicine.55.5727","article-title":"An adult case of anti-myelin oligodendrocyte glycoprotein (mog) antibody-associated multiphasic acute disseminated encephalomyelitis at 33-year intervals","volume":"55","author":"Numa","year":"2016","journal-title":"Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"582768","DOI":"10.3389\/fimmu.2021.582768","article-title":"The clinical features of FLAIR-hyperintense lesions in anti-mog antibody associated cerebral cortical encephalitis with seizures: case reports and literature review","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jdn.10106","article-title":"Antibody-positive cerebral cortical encephalitis: two case reports and literature review","volume":"81","author":"Tian","year":"2021","journal-title":"Int J Dev Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp-2016-315094","article-title":"Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies","volume":"88","author":"Fujimori","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"577898","DOI":"10.1016\/j.jneuroim.2022.577898","article-title":"Bilateral parafalcine cortical and leptomeningeal impairment: a characteristic pattern of MOG antibody disease and AQP4 neuromyelitis optica spectrum disorders?","volume":"369","author":"Jiang","year":"2022","journal-title":"J Neuroimmunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.seizure.2022.04.001","article-title":"Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: a case report and literature review","volume":"98","author":"Tokumoto","year":"2022","journal-title":"Seizure."},{"key":"B33","doi-asserted-by":"publisher","first-page":"577653","DOI":"10.1016\/j.jneuroim.2021.577653","article-title":"Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: a review","volume":"358","author":"Gombolay","year":"2021","journal-title":"J Neuroimmunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1001\/jamaneurol.2020.0001","article-title":"Unilateral leptomeningeal enhancement in myelin oligodendrocyte glycoprotein immunoglobulin G-associated disease","volume":"77","author":"Budhram","year":"2020","journal-title":"JAMA Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(21)00098-3","article-title":"Mitochondrial disease in adults: recent advances and future promise","volume":"20","author":"Ng","year":"2021","journal-title":"Lancet Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/practneurol-2015-001113","article-title":"Cortical abnormalities on MRI: what a neurologist should know","volume":"15","author":"Renard","year":"2015","journal-title":"Pract Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1148\/rg.2017160075","article-title":"Imaging of Creutzfeldt-Jakob disease: imaging patterns and their differential diagnosis","volume":"37","author":"Fragoso","year":"2017","journal-title":"Radiographics."},{"key":"B38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1212\/CPJ.0000000000000114","article-title":"Metabolic disorders with clinical and radiologic features of sporadic Creutzfeldt-Jakob disease","volume":"5","author":"Rosenbloom","year":"2015","journal-title":"Neurol Clin Pract."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.crad.2007.12.018","article-title":"Differential diagnosis of restricted diffusion confined to the cerebral cortex","volume":"63","author":"Sheerin","year":"2008","journal-title":"Clin Radiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1017\/cjn.2021.134","article-title":"FLAIR-hyperintense Lesion in anti-MOG-associated encephalitis with seizures (FLAMES)","volume":"49","author":"Mirian","year":"2022","journal-title":"Can J Neurol Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/jnnp-2021-326401","article-title":"Budhram, A. Unilateral cortical FLAIR-hyperintense Lesion in Anti-MOG-associated Encephalitis with Seizures (FLAMES) on TNF inhibitor therapy","volume":"92","author":"Chang","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/j.1528-1167.2011.03084.x","article-title":"Aphasic status epilepticus: electroclinical correlation","volume":"52","author":"Ericson","year":"2011","journal-title":"Epilepsia."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia."},{"key":"B44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B45","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1528-1167.2008.01565.x","article-title":"Seizures in multiple sclerosis","volume":"49","author":"Koch","year":"2008","journal-title":"Epilepsia."},{"key":"B46","doi-asserted-by":"publisher","first-page":"107099","DOI":"10.1016\/j.clineuro.2021.107099","article-title":"Epilepsia partialis continua in relapsing-remitting multiple sclerosis: a possible distinct relapse phenotype","volume":"213","author":"Jain","year":"2022","journal-title":"Clin Neurol Neurosurg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"912050","DOI":"10.3389\/fneur.2022.912050","article-title":"Testing for antibodies against aquaporin-4 and myelin oligodendrocyte glycoprotein in the diagnosis of patients with suspected autoimmune myelopathy","volume":"13","author":"Alkabie","year":"2022","journal-title":"Front Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1867","DOI":"10.1212\/WNL.0000000000008479","article-title":"Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases","volume":"93","author":"Mariotto","year":"2019","journal-title":"Neurology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"102283","DOI":"10.1016\/j.msard.2020.102283","article-title":"FLAIR-hyperintense lesions in Anti-MOG-associated encephalitis with seizures (FLAMES): is immunotherapy always needed to put out the fire?","volume":"44","author":"Budhram","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/jamaneurol.2022.0489","article-title":"Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"79","author":"Chen","year":"2022","journal-title":"JAMA Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-019-1525-1","article-title":"Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease","volume":"16","author":"Cobo-Calvo","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B54","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e2142780","DOI":"10.1001\/jamanetworkopen.2021.42780","article-title":"Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody-associated disease in the United Kingdom","volume":"5","author":"Satukijchai","year":"2022","journal-title":"JAMA Netw Open."},{"key":"B56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jns.2018.06.028","article-title":"The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: a case report","volume":"392","author":"Ikeda","year":"2018","journal-title":"J Neurol Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1212\/NXI.0000000000000538","article-title":"Anti-MOG encephalitis mimicking small vessel CNS vasculitis","volume":"6","author":"Patterson","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/brain\/awaa102","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study","volume":"143","author":"Takai","year":"2020","journal-title":"Brain."},{"key":"B59","doi-asserted-by":"publisher","first-page":"577322","DOI":"10.1016\/j.jneuroim.2020.577322","article-title":"Unilateral chronic pulsatile headache as the single manifestation of anti-MOG antibody-associated unilateral cerebral cortical encephalitis","volume":"346","author":"Fujimori","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.msard.2019.01.021","article-title":"Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease","volume":"29","author":"Salama","year":"2019","journal-title":"Mult Scler Relat Disord."},{"key":"B61","article-title":"Adding FUEL to the FLAMES: FLAIR-variable unilateral enhancement of the leptomeninges (FUEL) in MOG-IgG-Associated Disease (862)","author":"Budhram","year":"2020","journal-title":"AAN Enterprises."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1044642\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T01:15:39Z","timestamp":1666228539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1044642\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":61,"alternative-id":["10.3389\/fneur.2022.1044642"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.1044642","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"article-number":"1044642"}}